Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71, Journal of Virology, vol.87, issue.6, pp.3335-3347, 2013. ,
DOI : 10.1128/JVI.02070-12
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor, J Virol, vol.87, pp.611-620, 2013. ,
Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71, Journal of Virology, vol.88, issue.10, pp.5816-5833, 2014. ,
DOI : 10.1128/JVI.03826-13
Clinical features, diagnosis, and management of enterovirus 71, The Lancet Neurology, vol.9, issue.11, pp.1097-1105, 2010. ,
DOI : 10.1016/S1474-4422(10)70209-X
Structure of human enterovirus 71 in complex with a capsid-binding inhibitor, Proceedings of the National Academy of Sciences, vol.110, issue.14, pp.5463-5467, 2013. ,
DOI : 10.1073/pnas.1222379110
Selective inhibitors of picornavirus replication, Medicinal Research Reviews, vol.18, issue.Pt 1, pp.823-884, 2008. ,
DOI : 10.1002/med.20125
Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model, Antiviral Research, vol.97, issue.3, pp.264-269, 2013. ,
DOI : 10.1016/j.antiviral.2012.12.029
Enterovirus 71 and Coxsackievirus A16 3C Proteases: Binding to Rupintrivir and Their Substrates and Anti-Hand, Foot, and Mouth Disease Virus Drug Design, Journal of Virology, vol.85, issue.19, pp.10319-10331, 2011. ,
DOI : 10.1128/JVI.00787-11
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196414
In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection, Archives of Virology, vol.60, issue.4, pp.669-679, 2012. ,
DOI : 10.1007/s00705-011-1222-6
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71, Virus Research, vol.169, issue.1, pp.22-29, 2012. ,
DOI : 10.1016/j.virusres.2012.06.025
THE TREATMENT OF KALA-AZAR BY "BAYER 205.", BMJ, vol.1, issue.3244, p.370, 1923. ,
DOI : 10.1136/bmj.1.3244.370
Sleeping Sickness in Brothers in London, The Pediatric Infectious Disease Journal, vol.23, issue.9, pp.879-881, 2004. ,
DOI : 10.1097/01.inf.0000137587.80399.3b
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer, Cancer Chemotherapy and Pharmacology, vol.686, issue.6, pp.1019-1029, 2010. ,
DOI : 10.1007/s00280-010-1252-x
Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-related Compounds, Journal of General Virology, vol.68, issue.8, pp.2183-2192, 1987. ,
DOI : 10.1099/0022-1317-68-8-2183
Suramin prevents duck hepatitis B virus infection in vivo., Antimicrobial Agents and Chemotherapy, vol.37, issue.7, pp.1539-1542, 1993. ,
DOI : 10.1128/AAC.37.7.1539
Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications, Virology Journal, vol.9, issue.1, p.8, 2012. ,
DOI : 10.1128/JVI.00434-09
Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication, Virology Journal, vol.8, issue.1, p.483, 2011. ,
DOI : 10.1016/0168-1702(95)00087-9
Pathogenesis study of enterovirus 71 infection in rhesus monkeys, Laboratory Investigation, vol.83, issue.9, pp.1337-1350, 2011. ,
DOI : 10.1111/j.1574-6976.2002.tb00601.x
Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine, PLoS ONE, vol.13, issue.1, p.54451, 2013. ,
DOI : 10.1371/journal.pone.0054451.s003
Avian Influenza H5-Containing Virus-Like Particles (VLPs): Host-Cell Receptor Specificity by STD NMR Spectroscopy, Angewandte Chemie International Edition, vol.6, issue.10, pp.1910-1912, 2008. ,
DOI : 10.1002/anie.200704872
URL : https://hal.archives-ouvertes.fr/pasteur-00588962
Sialic acid dependence in rotavirus host cell invasion, Nature Chemical Biology, vol.367, issue.2, pp.91-93, 2009. ,
DOI : 10.1038/nchembio.134
Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation, Journal of General Virology, vol.85, issue.10, pp.2981-2989, 2004. ,
DOI : 10.1099/vir.0.79883-0
Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection, Virology, vol.412, issue.1, pp.91-100, 2011. ,
DOI : 10.1016/j.virol.2010.12.058
Addressing the barriers to pediatric drug development: workshop summary, 2008. ,
New uses for old drugs, Nature, vol.34, issue.7154, pp.645-646, 2007. ,
DOI : 10.1038/448645a
Antiparasitic Therapy, Mayo Clinic Proceedings, vol.86, issue.6, pp.561-583, 2011. ,
DOI : 10.4065/mcp.2011.0203
Human antiprotozoal therapy: past, present, and future, Clin Microbiol Rev, vol.8, pp.427-439, 1995. ,
Suramin's development: what did we learn?, Invest New Drugs, vol.20, pp.209-219, 2002. ,
Use of adaptive control with feedback to individualize suramin dosing, Cancer Res, vol.52, pp.64-70, 1992. ,
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response, Cancer Chemotherapy and Pharmacology, vol.39, issue.1-2, pp.1-8, 1996. ,
DOI : 10.1007/s002800050531
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes, Cancer Chemotherapy and Pharmacology, vol.26, issue.10, pp.49-56, 2012. ,
DOI : 10.1007/s00280-012-1887-x
Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71, Journal of Medical Virology, vol.17, issue.2, pp.207-216, 2002. ,
DOI : 10.1002/jmv.2209
Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy, Current Pharmaceutical Design, vol.10, issue.30, pp.3701-3712, 2004. ,
DOI : 10.2174/1381612043382729
Blocking HCV entry as potential antiviral therapy, Future Virology, vol.7, issue.6, pp.547-561, 2012. ,
DOI : 10.2217/fvl.12.47
Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1, Journal of Medicinal Chemistry, vol.55, issue.10, pp.4764-4775, 2012. ,
DOI : 10.1021/jm3002247
Pleconaril???an advance in the treatment of enteroviral infection in immuno-compromised patients, Journal of Clinical Virology, vol.32, issue.1, pp.1-6, 2005. ,
DOI : 10.1016/j.jcv.2004.06.006
Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity, Journal of General Virology, vol.89, issue.10, pp.2518-2530, 2008. ,
DOI : 10.1099/vir.0.2008/002915-0
Protein Binding: Do We Ever Learn?, Antimicrobial Agents and Chemotherapy, vol.55, issue.7, pp.3067-3074, 2011. ,
DOI : 10.1128/AAC.01433-10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122431